Generic Name and Formulations:
Diclofenac sodium 3%; gel; contains benzyl alcohol.
Indications for SOLARAZE:
Use lowest effective dose for shortest duration. Apply to lesions twice daily for 60–90 days.
Coronary artery bypass graft surgery.
Risk of serious cardiovascular events.
Increased risk of serious cardiovascular events (including MI, stroke). Avoid in recent MI, severe heart failure; if necessary, monitor. History of ulcer disease and/or GI bleeding. Severe renal or hepatic impairment. Avoid sun and UV light. Aspirin allergy. Asthma. Avoid eyes, and open skin wounds, infections, or exfoliative dermatitis. Elderly. Labor & delivery. Pregnancy (Cat.B); avoid in 3rd trimester. Nursing mothers: not recommended.
Increased risk of GI events with concomitant aspirin or oral NSAIDs. Concomitant other topical medications or products (eg, sunscreens, cosmetics): not studied.
Pruritus, rash, contact dermatitis, dry skin, exfoliation, local pain, paresthesia; cardiovascular thrombotic events, edema, photosensitivity.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- ADHD Medications Compared for Efficacy, Tolerability in Children and Adults
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation